Vimarsana
Biggest News Aggregation in the World

Page 2 - Treatment Protocol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Treatment Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Treatment Protocol Today - Breaking & Trending Today

Five-year survival rate for children with acute lymphatic leukemia has increased: Study - Vimarsana News

Five-year survival rate for children with acute lymphatic leukemia has increased: Study

The study results of the ALL-11 treatment protocol, led by researchers at the Princess Maxima Center, were published in the scientific Journal of Clinical Oncology.

Tebentafusp Treatment Protocol in Metastatic Uveal Melanoma - Vimarsana News

Tebentafusp Treatment Protocol in Metastatic Uveal Melanoma

An expert on uveal melanoma reviews the treatment protocol for tebentafusp, which is approved for the treatment of metastatic disease.

Changes to the diagnosis and treatment of COV - Vimarsana News

Changes to the diagnosis and treatment of COV

An article in Health Care Science provides an in-depth analysis of the changes made to the diagnosis and treatment protocol for COVID-19 in China over the course of the pandemic.

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements - Vimarsana News

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements

MACAU, May 10, 2023 /PRNewswire/ -- From May 10 to 12, 2023, the 3rd BEYOND International Technology Innovation Expo — also known as BEYOND Expo 2023 is being held at the Venetian Macau... | May 10, 2023

Does every heart patient need a beta blocker for life? Who should continue for long? New study throws light - Vimarsana News

Does every heart patient need a beta blocker for life? Who should continue for long? New study throws light

Beta blockers are magical for heart failure, angina or arrhythmia because they are life-saving in such situations. What the study clarifies is their selective and graded use and whether those with normal cardiac functionality need them life-long, says Dr Balbir Singh, Chairman, Cardiac Sciences, Cardiology, Cardiac, Electrophysiology-Pacemaker, Max Hospitals, Delhi